Search results
Found 30417 matches for
Hal Drakesmith (Investigative Medicine Division, WIMM, RDM) and Simon Draper (Jenner Institute, NDM) have been awarded a Pfizer Rare Disease Consortium grant. This is one of 3 grants awarded to Oxford under the Pfizer Rare Disease Consortium with GMEC Universities (Global Medical Excellence Cluster).
Neubauer Group: Oxford Centre for Clinical Magnetic Resonance Research
OCMR uses sophisticated cardiac MR imaging and spectroscopy methods to phenotype cardiovascular disease – in small-scale proof-of-principle studies, large-scale multicentre clinical trials and ultra-large scale population imaging programmes. As well as running their own research programmes, OCMR serves as a collaboration partner to any group wanting to strengthen their clinical research with state of the art non-invasive phenotyping tools.
How to find us
How to find the Diabetes Trials Unit
Publications
DTU Publications
Tyler Group: Development and Application of Cardiac Magnetic Resonance Imaging and Spectroscopy
Using metabolic imaging to transform our approach to disease detection and treatment.
EVAREST (Echocardiography - Value and Accuracy at Rest and Stress)
EVAREST is CCRF-led multi-centre trial which aims to identify and validate novel blood and imaging biomarkers of potential value for consistent and accurate interpretation of stress echocardiography.
DPhil research opportunities
Find out about DPhil Research Opportunities available in 2020.